We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: Jury in Elizabeth Holmes Trial Ends Fourth Day of Deliberations
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Technology > Jury in Elizabeth Holmes Trial Ends Fourth Day of Deliberations
Jury in Elizabeth Holmes Trial Ends Fourth Day of Deliberations
Technology

Jury in Elizabeth Holmes Trial Ends Fourth Day of Deliberations

Last updated: December 28, 2021 4:48 am
Editorial Board Published December 28, 2021
Share
SHARE
27holmes deliberations facebookJumbo

SAN JOSE, Calif. — Jurors ended a fourth day of deliberations without a verdict on Monday in the fraud trial of Elizabeth Holmes, the founder of the failed blood testing start-up Theranos.

Ms. Holmes, 37, faces 11 counts of wire fraud and conspiracy to commit wire fraud over charges that she lied about Theranos’s technology as she sought investments and business for her start-up. If convicted, she faces up to 20 years in prison for each count of wire fraud.

A jury of eight men and four women also deliberated last Monday, Tuesday and Thursday. They are scheduled to return to federal court in San Jose, Calif., at 8:30 a.m. Tuesday to resume deliberations.

On Thursday, they asked to hear recordings of a call Ms. Holmes had with investors, in which she allegedly made misleading claims about Theranos’s partnerships with pharmaceutical companies and the military.

The jurors’ deliberations follow a nearly four-month trial that is viewed as a referendum on the worst excesses of Silicon Valley’s start-up culture. Before Theranos collapsed, Ms. Holmes was a highly celebrated female founder. She dropped out of Stanford University at age 19 to focus on her company and spent the next decade raising nearly $1 billion from investors.

In 2015, Theranos began to unravel after a Wall Street Journal investigation revealed that the company had relied on commercially available machines to perform many of its blood tests, rather than its own supposedly revolutionary devices. Theranos shut down in 2018, the same year Ms. Holmes was indicted.

During the trial, federal prosecutors have tried to prove that Ms. Holmes intentionally deceived investors, patients and commercial partners by forging validation reports, faking demonstrations and misrepresenting Theranos to the media and the public.

​​“She chose fraud over business failure,” Jeffrey Schenk, an assistant U.S. attorney, said during the government’s closing argument.

Ms. Holmes, who took the stand for seven days in her own defense, has tried painting herself as a well-meaning entrepreneur who believed her own claims and was led astray by those around her.

“She believed she was building a technology that would change the world,” said Kevin Downey, a lawyer for Ms. Holmes.

You Might Also Like

Why AI is making us lose our minds (and never in the way in which you’d assume)

Meta broadcasts its Superintelligence Labs Chief Scientist: former OpenAI GPT-4 co-creator Shengjia Zhao

New AI structure delivers 100x quicker reasoning than LLMs with simply 1,000 coaching examples

CoSyn: The open-source device that’s making GPT-4V-level imaginative and prescient AI accessible to everybody

It’s Qwen’s summer season: new open supply Qwen3-235B-A22B-Pondering-2507 tops OpenAI, Gemini reasoning fashions on key benchmarks

TAGGED:Computers and the InternetEntrepreneurshipFrauds and SwindlingHolmes, Elizabeth (1984- )Silicon Valley (Calif)Start-upsTests (Medical)The Washington MailTheranos IncVenture Capital
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
What’s a Plat Map? Right here’s What You Have to Know
Real Estate

What’s a Plat Map? Right here’s What You Have to Know

Editorial Board June 18, 2025
Jets maintain on to defeat Jaguars after Davante Adams’ large day in Jacksonville
Ex-Jets coach Robert Saleh will interview for Jaguars teaching place
Federal Judge Temporarily Blocks Enforcement of L.G.B.T.Q. Protections
2 Police Officers Killed in Connecticut After a Suspicious 911 Call

You Might Also Like

Freed says 20,000 clinicians are utilizing its medical AI transcription ‘scribe,’ however competitors is rising quick
Technology

Freed says 20,000 clinicians are utilizing its medical AI transcription ‘scribe,’ however competitors is rising quick

July 25, 2025
Anthropic unveils ‘auditing agents’ to check for AI misalignment
Technology

Anthropic unveils ‘auditing agents’ to check for AI misalignment

July 25, 2025
Freed says 20,000 clinicians are utilizing its medical AI transcription ‘scribe,’ however competitors is rising quick
Technology

SecurityPal combines AI and consultants in Nepal to hurry enterprise safety questionnaires by 87X or extra

July 24, 2025
Freed says 20,000 clinicians are utilizing its medical AI transcription ‘scribe,’ however competitors is rising quick
Technology

White Home plan alerts “open-weight first” period—and enterprises want new guardrails

July 24, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • World
  • Art

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?